Business Wire
BusinessReport: Exxon Mobil joins bidders for Shell’s U.S. chemicals assets, a potential shift for XOM’s refining-and-chemicals outlookThe Apex TimesBusinessUPS says its reorganization will lean more heavily on global logistics than domestic parcel operationsThe Apex TimesBusinessGeneral Dynamics shares fall more than the broader market in late-session tradingThe Apex TimesBusinessEli Lilly to buy Merdia Biosciences in a deal valued at up to $2.88 billion, indicating renewed focus on pipeline expansionThe Apex TimesBusinessNvidia hardware momentum meets a new choke point: copper, not cash, HIVE Digital’s Frank Holmes saysThe Apex TimesBusinessBroadcom’s Sept. 2 earnings set up a high-stakes test for its AI narrativeThe Apex TimesBusinessPalantir CEO Alex Karp pushes back on “tokenmaxxing,” pitching real-world AI value over hypeThe Apex TimesBusinessFTC and 22 states sue Amazon, alleging inflated prices in online ads schemeThe Apex TimesBusinessTesla shares rise after investors refocus on long-term autonomous driving potentialThe Apex TimesBusinessTim Cook’s final day as Apple CEO caps a 15-year push into services, wearables and paymentsThe Apex TimesBusinessNetflix announces new original comedy led by Camila Pitanga and Sergio GuizéThe Apex TimesBusinessWall Street stays upbeat on GE Aerospace after the shares outpace the NasdaqThe Apex TimesBusinessReport: Exxon Mobil joins bidders for Shell’s U.S. chemicals assets, a potential shift for XOM’s refining-and-chemicals outlookThe Apex TimesBusinessUPS says its reorganization will lean more heavily on global logistics than domestic parcel operationsThe Apex TimesBusinessGeneral Dynamics shares fall more than the broader market in late-session tradingThe Apex TimesBusinessEli Lilly to buy Merdia Biosciences in a deal valued at up to $2.88 billion, indicating renewed focus on pipeline expansionThe Apex TimesBusinessNvidia hardware momentum meets a new choke point: copper, not cash, HIVE Digital’s Frank Holmes saysThe Apex TimesBusinessBroadcom’s Sept. 2 earnings set up a high-stakes test for its AI narrativeThe Apex TimesBusinessPalantir CEO Alex Karp pushes back on “tokenmaxxing,” pitching real-world AI value over hypeThe Apex TimesBusinessFTC and 22 states sue Amazon, alleging inflated prices in online ads schemeThe Apex TimesBusinessTesla shares rise after investors refocus on long-term autonomous driving potentialThe Apex TimesBusinessTim Cook’s final day as Apple CEO caps a 15-year push into services, wearables and paymentsThe Apex TimesBusinessNetflix announces new original comedy led by Camila Pitanga and Sergio GuizéThe Apex TimesBusinessWall Street stays upbeat on GE Aerospace after the shares outpace the NasdaqThe Apex TimesBusinessReport: Exxon Mobil joins bidders for Shell’s U.S. chemicals assets, a potential shift for XOM’s refining-and-chemicals outlookThe Apex TimesBusinessUPS says its reorganization will lean more heavily on global logistics than domestic parcel operationsThe Apex TimesBusinessGeneral Dynamics shares fall more than the broader market in late-session tradingThe Apex TimesBusinessEli Lilly to buy Merdia Biosciences in a deal valued at up to $2.88 billion, indicating renewed focus on pipeline expansionThe Apex TimesBusinessNvidia hardware momentum meets a new choke point: copper, not cash, HIVE Digital’s Frank Holmes saysThe Apex TimesBusinessBroadcom’s Sept. 2 earnings set up a high-stakes test for its AI narrativeThe Apex TimesBusinessPalantir CEO Alex Karp pushes back on “tokenmaxxing,” pitching real-world AI value over hypeThe Apex TimesBusinessFTC and 22 states sue Amazon, alleging inflated prices in online ads schemeThe Apex TimesBusinessTesla shares rise after investors refocus on long-term autonomous driving potentialThe Apex TimesBusinessTim Cook’s final day as Apple CEO caps a 15-year push into services, wearables and paymentsThe Apex TimesBusinessNetflix announces new original comedy led by Camila Pitanga and Sergio GuizéThe Apex TimesBusinessWall Street stays upbeat on GE Aerospace after the shares outpace the NasdaqThe Apex TimesBusinessReport: Exxon Mobil joins bidders for Shell’s U.S. chemicals assets, a potential shift for XOM’s refining-and-chemicals outlookThe Apex TimesBusinessUPS says its reorganization will lean more heavily on global logistics than domestic parcel operationsThe Apex TimesBusinessGeneral Dynamics shares fall more than the broader market in late-session tradingThe Apex TimesBusinessEli Lilly to buy Merdia Biosciences in a deal valued at up to $2.88 billion, indicating renewed focus on pipeline expansionThe Apex TimesBusinessNvidia hardware momentum meets a new choke point: copper, not cash, HIVE Digital’s Frank Holmes saysThe Apex TimesBusinessBroadcom’s Sept. 2 earnings set up a high-stakes test for its AI narrativeThe Apex TimesBusinessPalantir CEO Alex Karp pushes back on “tokenmaxxing,” pitching real-world AI value over hypeThe Apex TimesBusinessFTC and 22 states sue Amazon, alleging inflated prices in online ads schemeThe Apex TimesBusinessTesla shares rise after investors refocus on long-term autonomous driving potentialThe Apex TimesBusinessTim Cook’s final day as Apple CEO caps a 15-year push into services, wearables and paymentsThe Apex TimesBusinessNetflix announces new original comedy led by Camila Pitanga and Sergio GuizéThe Apex TimesBusinessWall Street stays upbeat on GE Aerospace after the shares outpace the NasdaqThe Apex Times
Back to front
GLP-1s hit demand for processed “big food” snacks, nudging investors toward PepsiCo and Smucker
The Apex Times

THE APEX TIMES

Business/The Apex Times/Aug 19, 11:26 AM EDT

GLP-1s hit demand for processed “big food” snacks, nudging investors toward PepsiCo and Smucker

A widely traded set of packaged-food brands is facing investor skepticism as Americans shift eating habits under GLP-1 weight-loss drugs. The latest market read points to PepsiCo’s Uncrustables and Smucker’s related jam and peanut-butter footprint as potential places to look amid volatility.

Investors are increasingly treating parts of the packaged-food universe as if they are fighting the same headwind, diet pills. A new Yahoo Finance market note argues that so-called GLP-1 “indigestion” is weighing on Big Food stocks, pushing some traders to search for bargains in companies tied to specific categories of processed foods that have been disrupted less than the sector headline suggests.

The post highlights PepsiCo as one example, pointing to the company’s Uncrustables line of frozen peanut-butter-and-jelly sandwiches. Uncrustables, which are shelf-stable frozen snacks sold as ready-to-eat PB&J, have become a material driver for PepsiCo’s growth story. The note says Uncrustables annual sales have recently topped $1 billion and that the product now represents more than 10% of PepsiCo’s overall business mix.

In the same view, the market narrative extends beyond PepsiCo to The J.M. Smucker Company. Smucker is known for its consumer food brands, including jams and peanut-butter products that feed into the broader PB&J category. Yahoo’s framing suggests that, while GLP-1-related behavior change can affect demand across “big food” in general, it does not automatically erase value for firms that own specific, high-volume products.

A key point in the Yahoo note is that the market’s reaction may be disproportionate to the fundamentals in at least some product niches. By calling for “bargains” in PepsiCo and Smucker, the post is effectively arguing that investors may be discounting the entire category based on the most visible dietary trends, rather than separating out which brands are losing share and which are holding up.

PepsiCo’s positioning matters because the company’s exposure is not limited to any single consumer taste. The company sells a broad set of drinks and snack foods, and its Uncrustables franchise is one of the clearer, identifiable “growth engines” mentioned in the post. When a product category is treated as high-growth and resilient, investors may be more willing to separate it from wider macro fears around processed foods.

That said, the Yahoo market note does not provide a detailed breakdown of how GLP-1 usage is translating into PepsiCo-specific demand changes. It also does not disclose a recent quarter-by-quarter trend for Uncrustables in the excerpted material available for this write-up. In other words, the argument that Uncrustables can offset broader “GLP-1” pressure is asserted at the product level, but without the full data trail in the provided text.

Looking ahead, what to watch is whether PepsiCo’s management discusses category demand and promotions for frozen snacks and whether investors continue rotating into names tied to branded processed foods rather than exiting them wholesale. For Smucker, attention will likely focus on how the company’s relevant spreads and brands track the same behavioral shift, and whether the market’s “bargain” framing holds as more detailed performance information becomes available.

For now, the clearest measurable claim in the provided material is the magnitude of Uncrustables: more than $1 billion in annual sales recently, and more than 10% of PepsiCo’s business. The rest of the story, including the precise size of any GLP-1-driven slowdown and its impact by brand and channel, remains unspecified in the available post and would need company commentary or filings to confirm.

Why It Matters

  • If GLP-1-driven eating changes are reshaping demand, investors may increasingly differentiate within packaged foods rather than treating the sector as one trade.
  • A brand-level growth engine like Uncrustables, if resilient, can offset broader fears about processed-food consumption.
  • The “bargain” call suggests valuation dispersion may widen across packaged-food equities tied to different product categories.
  • Expect more attention on management commentary about category demand, promotions, and volume trends as evidence of GLP-1 impact accumulates.

Sources

Key Facts

  • Yahoo Finance’s market note argues that GLP-1 weight-loss drugs are pressuring sentiment toward “big food” packaged-stock names.
  • The note points to PepsiCo’s Uncrustables frozen peanut-butter-and-jelly sandwiches as a growth driver.
  • The post says Uncrustables annual sales have recently topped $1 billion.
  • The post says Uncrustables now accounts for more than 10% of PepsiCo’s business mix.
  • The post frames The J.M. Smucker Company as a potential beneficiary within the same broader PB&J/jam-and-spread category exposure.
  • The provided material does not include supporting quarterly breakdowns or company guidance about GLP-1 demand effects.

Retail & Consumer Related

Aug 31, 2:06 PM EDT
The Apex Times

Walmart climbs as oil at $90 bolsters the “defensive” appeal of retailers

Investors are treating cheaper-to-own retail as a buffer again, after a sharp move in crude oil toward $90. The shift could help Walmart capture shoppers “trading down,” but higher fuel and inventory costs also pose a risk to the cash profits that support its valuation.

Walmart climbs as oil at $90 bolsters the “defensive” appeal of retailers
The Apex Times
GLP-1s hit demand for processed “big food” snacks, nudging investors toward PepsiCo and Smucker | The Apex Times